RedChip Independent Initiates Research Coverage on CytRx Corp.
... human therapeutic products primarily based on small molecule Molecular Chaperone co-induction technology. Harry Russell, MBA, RedChip Research Analyst, reported: "CytRx develops products based on the belief that stresses on ...
More...
... human therapeutic products primarily based on small molecule Molecular Chaperone co-induction technology. Harry Russell, MBA, RedChip Research Analyst, reported: "CytRx develops products based on the belief that stresses on ...
More...